Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Merck Makes Changes At Riverside Plant

by Ann M. Thayer
April 25, 2011 | A version of this story appeared in Volume 89, Issue 17

Merck & Co. has told employees at its facility in Riverside, Pa., that it will cut back operations by the end of 2013. After being sold to PWRT Services in 2008, the plant became known as Cherokee Pharmaceuticals. Then, last summer, it was sold back to Merck after PWRT found the contract manufacturing business too challenging. Merck plans for the site to focus on producing the antibiotic ingredients imipenem, cilastatin, and ertapenem. Other product manufacturing and a third-party fermentation business will be outsourced or sold. It is not yet known to what extent jobs will be cut.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.